Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Completed 3Unknown 1Enrolling by invitation 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Genitourinary 3

Conditions

Prostatic Neoplasms 3Infections 2

Interventions

Cyclophosphamide 1492Cisplatin 1414Paclitaxel 1317Radiotherapy 1261Carboplatin 1250Gemcitabine 1215Docetaxel 1109Bevacizumab 1030Fluorouracil 894Doxorubicin 792Dexamethasone 748Rituximab 719Capecitabine 716Oxaliplatin 700pembrolizumab 680Etoposide 678Irinotecan 634Filgrastim 621Cytarabine 586Leucovorin 579Nivolumab 558Vincristine 515Prednisone 475Cetuximab 465Bortezomib 459Erlotinib Hydrochloride 456Trastuzumab 447Methotrexate 438Lenalidomide 427Pemetrexed 420

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Interventional × Antibiotic Prophylaxis × Clear all
NCT04815876 2026-02-20

PREVENT2

Weill Medical College of Cornell University

Phase NA Completed
1,030 enrolled
Genitourinary

Infections, Prostatic Neoplasms

NCT04843566 2025-04-15

PREVENT

Weill Medical College of Cornell University

Phase NA Completed
687 enrolled 11 charts
Genitourinary

Infections, Prostatic Neoplasms

NCT04146142 2021-12-07

NORAPP

Oslo University Hospital

Phase NA Completed
550 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡